Non-High-Density Lipoprotein and Very-Low-Density Lipoprotein Cholesterol and Their Risk Predictive Values in Coronary Heart Disease

American Journal of Cardiology

Volumn 98, Issue 10, 2006, Pages 1363-1368

  Liu, Jian ^a   Sempos, Christopher T ^b   Donahue, Richard P ^c   Dorn, Joan ^c   Trevisan, Maurizio ^c   Grundy, Scott M ^d  

^a BROCK UNIVERSITY   (Canada)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; DATA ANALYSIS; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; CORONARY DISEASE; FEMALE; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 33750527116     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.06.032     Document Type: Article

References (26)

1. Dawber T. The Framingham Study-The Epidemiology of Atherosclerotic Disease (1980), Harvard University Press, Cambridge, MA
2. Kannel W.B., Feinlei M., McNamara P.M., Garrison R.J., and Castelli W.P. An investigation of coronary heart disease in families-the Framingham Offspring Study. Am J Epidemiol 110 (1979) 281-290
3. Abell L.L., Levy R.I., Brodie B., and Kendall F. Simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 195 (1952) 357-366
4. Friedewald W., Levy R., and Fredrickson D. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem 18 (1972) 499-502
5. National Heart, Lung, and Blood Institute. LRC Program: Manual of Laboratory Options, Manual of Laboratory Operations: Lipid and Lipoprotein Analysis Vol 1 (1982), National Heart, Lung, and Blood Institute, Bethesda, MD
6. Kessler G., and Lederer H. Fluorometric measurements of triglycerides. In: Skeggs L.T. (Ed). Technicon Symposia: Automation in Analytical Chemistry (1965), Mediad, New York, NY 341-344
7. NCEP Expert Panel. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
8. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20 (1997) 1183-1197
9. Kahn H., and Sempos C. Statistical Methods in Epidemiology (1989), Oxford University Press, New York, NY
10. Grundy S.M. Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy. Circulation 106 (2002) 2526-2529
11. Pocock S.J., Shaper A.G., Phillips A.N., Walker M., and Whitehead T.P. High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men. BMJ (Clin Res Ed) 292 (1986) 515-519
12. Menotti A., Spagnolo A., Scanga M., and Dima F. Multivariate prediction of coronary deaths in a 10 year follow-up of an Italian occupational male cohort. Acta Cardiol 47 (1992) 311-320
13. Keys A., Karvonen M.J., Punsar S., Menotti A., Fidanza F., and Farchi G. HDL serum cholesterol and 24-year mortality of men in Finland. Int J Epidemiol 13 (1984) 428-435
14. Gordon D.J., Probstfield J.L., Garrison R.J., Neaton J.D., Castelli W.P., Knoke J.D., Jacobs Jr. D.R., Bangdiwala S., and Tyroler H.A. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79 (1989) 8-15
15. Cui Y., Blumenthal R.S., Flaws J.A., Whiteman M.K., Langenberg P., Bachorik P.S., and Bush T.L. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 161 (2001) 1413-1419
16. Jiang R., Schulze M.B., Li T., Rifai N., Stampfer M.J., Rimm E.B., and Hu F.B. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. Diabetes Care 27 (2004) 1991-1997
17. Lu W., Resnick H.E., Jablonski K.A., Jones K.L., Jain A.K., Howard W.J., Robbins D.C., and Howard B.V. Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the Strong Heart Study. Diabetes Care 26 (2003) 16-23
18. Liu J., Sempos C., Donahue R., Dorn J., Trevisan M., and Grundy S. The joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Diabetes Care 28 (2005) 1916-1921
19. Sacks F.M., Tonkin A.M., Craven T., Pfeffer M.A., Shepherd J., Keech A., Furberg C.D., and Braunwald E. Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors. Circulation 105 (2002) 1424-1428
20. Grundy S.M. Non-high-density lipoprotein cholesterol level as potential risk predictor and therapy target. Arch Intern Med 161 (2001) 1379-1380
21. Austin M. Plasma triglyceride and coronary heart disease. Arterioscler Thromb 11 (1991) 2-14
22. Bittner V., Hardison R., Kelsey S.F., Weiner B.H., Jacobs A.K., and Sopko G. Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 106 (2002) 2537-2542
23. Gardner C.D., Fortmann S.P., and Krauss R.M. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 276 (1996) 875-881
24. Laakso M., Lehto S., Penttila I., and Pyorala K. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 88 (1993) 1421-1430
25. Phillips N., Water D., and Havel R. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 88 (1993) 2762-2770
26. Kugiyama K., Doi H., Takazoe K., Kawano H., Soejima H., Mizuno Y., Tsunoda R., Sakamoto T., Nakano T., Nakajima K., et al. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation 99 (1999) 2858-2860